Literature DB >> 24456871

Heme iron intake and acute myocardial infarction: a prospective study of men.

Joanna Kaluza1, Susanna C Larsson2, Niclas Håkansson2, Alicja Wolk2.   

Abstract

BACKGROUND: Epidemiologic studies of heme iron and non-heme iron intake in relation to risk of acute myocardial infarction (AMI) are lacking. Therefore, we examine the associations between heme iron and non-heme iron intake and fatal and nonfatal AMI in men. Moreover, we investigated whether the associations were modified by intake of minerals (calcium, magnesium, and zinc) that decreases iron absorption.
METHODS: The population-based prospective cohort of Swedish Men (COSM) included 36882 men, aged 45-79 years, who completed a self-administered questionnaire on diet and had no history of coronary heart disease, stroke, diabetes, or cancer at baseline.
RESULTS: During an 11.7 year follow-up, 678 fatal and 2593 nonfatal AMI events were registered. The hazard ratio (HR) of fatal AMI among men in the highest compared with the lowest quintile of heme iron intake was 1.51 (95%CI: 1.07-2.13, P-trend=0.02). The association was confined to men with a low intake of minerals that can decrease iron absorption. Among men with combined intakes of calcium, magnesium, and zinc below the medians, the HR of fatal AMI was 2.89 (95%CI: 1.43-5.82) for the highest vs. the lowest quintile of heme iron intake. There was no association between heme iron intake and nonfatal AMI, or between non-heme iron intake and fatal or nonfatal AMI.
CONCLUSIONS: Findings from this prospective study indicate that a high heme iron intake, particularly with simultaneous low intake of minerals that can decrease iron absorption, may increase the risk of fatal AMI.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Heme iron; Non-heme iron; Prospective cohort study

Mesh:

Substances:

Year:  2014        PMID: 24456871     DOI: 10.1016/j.ijcard.2013.12.176

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice.

Authors:  Akiyo Eguchi; Yoshiro Naito; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Hisashi Sawada; Koichi Nishimura; Makiko Oboshi; Kenichi Fujii; Toshiaki Mano; Tohru Masuyama; Shinichi Hirotani
Journal:  Heart Vessels       Date:  2015-01-09       Impact factor: 2.037

Review 2.  The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.

Authors:  Xuexian Fang; Hossein Ardehali; Junxia Min; Fudi Wang
Journal:  Nat Rev Cardiol       Date:  2022-07-04       Impact factor: 49.421

3.  Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.

Authors:  Yoshiro Naito; Manami Hosokawa; Hisashi Sawada; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Koichi Nishimura; Yuko Soyama; Shinichi Hirotani; Toshiaki Mano; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-06-16       Impact factor: 2.037

4.  Temporary dietary iron restriction affects the process of thrombus resolution in a rat model of deep vein thrombosis.

Authors:  Makiko Oboshi; Yoshiro Naito; Hisashi Sawada; Shinichi Hirotani; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Koichi Nishimura; Kenichi Fujii; Toshiaki Mano; Masaharu Ishihara; Tohru Masuyama
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.

Authors:  Ying-Hsien Huang; Ho-Chang Kuo; Fu-Chen Huang; Hong-Ren Yu; Kai-Sheng Hsieh; Ya-Ling Yang; Jiunn-Ming Sheen; Sung-Chou Li; Hsing-Chun Kuo
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

6.  Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease.

Authors:  Ying-Hsien Huang; Kuender D Yang; Yu-Wen Hsu; Hsing-Fang Lu; Henry Sung-Ching Wong; Hong-Ren Yu; Hsing-Chun Kuo; Fu-Chen Huang; Mao-Hung Lo; Kai-Sheng Hsieh; Su-Fen Chen; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  Oncotarget       Date:  2017-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.